- South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine News-Medical.Net
- Researchers race to develop antiviral weapons to fight the pandemic coronavirus Science Magazine
- ImmunityBio Announces Novel ACE2 Decoy COVID-19 Therapeutic that Shows High Binding to SARS-CoV-2 Variants and Neutralizes Live Viruses Yahoo Finance
- Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations News-Medical.Net
- How the U.S. Pandemic Response Went Wrong--and What Went Right--During a Year of COVID Scientific American
- View Full coverage on Google News
South African SARS-CoV-2 variant most problematic for BNT-162b2 vaccine – News-Medical.Net
ByGoogle News
Mar 10, 2021